# CTKB (Cytek Biosciences, Inc.) - SEC EDGAR Financial Statements

> Cytek Biosciences, Inc. reported $207.6M in revenue and a net loss of $81.20M for the trailing twelve months ended September 30, 2026 (up 1.8% year over year), with a 54.7% gross margin and a -21.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/CTKB
- Markdown: https://convexityos.com/fundamentals/CTKB.md
- SEC CIK: 0001831915
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:32 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001831915&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $207.6M | +1.8% YoY |
| Operating Income | TTM | -$43.88M | -21.1% margin |
| Net Income | TTM | -$81.20M | -39.1% net margin |
| Diluted EPS | TTM | -$0.62 | Split-adjusted |
| Free Cash Flow | TTM | -$13.48M | -6.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $66.81M | Total debt: $16.23M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $201.5M | $200.5M | $193.0M | $2.96M | $2.18M | $710K |
| Cost of Revenue | $97.03M | $89.35M | $83.59M | $63.06M | $48.81M | $41.13M |
| **Gross Profit** | $104.5M | $111.1M | $109.4M | $101.0M | $79.14M | $51.71M |
| Research & Development | $36.47M | $39.40M | $44.15M | $34.86M | $24.44M | $13.69M |
| Selling, General & Admin | $108.4M | $92.23M | $93.12M | $67.92M | $45.55M | $24.36M |
| Total Operating Expenses | $144.8M | $131.6M | $137.3M | $102.8M | $69.99M | $38.05M |
| **Operating Income** | -$40.38M | -$20.52M | -$27.84M | -$1.80M | $9.16M | $13.66M |
| **EBITDA** | -$32.80M | -$13.31M | -$21.80M | $688K | $10.40M | $14.26M |
| Interest Income | $2.22M | $5.12M | $6.41M | $4.62M | $49K | $110K |
| Interest Expense | $474K | -$5.24M | $2.07M | $2.57M | $1.74M | $333K |
| Income Before Tax | -$29.84M | -$5.70M | -$15.71M | $1.26M | $5.94M | $14.43M |
| Income Tax Expense | $36.70M | $320K | -$3.56M | -$1.22M | $2.91M | -$4.98M |
| **Net Income** | -$66.54M | -$6.02M | -$12.15M | $2.48M | $3.03M | $19.41M |
| Basic EPS | -- | -- | -$0.09 | $0.02 | $0.00 | $0.08 |
| **Diluted EPS** | -- | -- | -$0.09 | $0.02 | $0.00 | $0.07 |
| Basic Shares Outstanding | 127.7M | 130.6M | 135.3M | 134.5M | 76.7M | 38.8M |
| Diluted Shares Outstanding | 127.7M | 130.6M | 135.3M | 138.6M | 81.5M | 43.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $53.23M | $48.14M | $44.13M | $62.14M | $52.29M | $45.60M | $41.46M | $57.48M |
| Cost of Revenue | $22.02M | $19.80M | $22.88M | $29.26M | $24.74M | $21.73M | $21.30M | $23.82M |
| **Gross Profit** | $31.21M | $28.34M | $21.25M | $32.88M | $27.55M | $23.87M | $20.16M | $33.65M |
| Research & Development | $9.36M | $9.74M | $9.60M | $8.96M | $8.96M | $8.83M | $9.72M | $9.72M |
| Selling, General & Admin | $30.27M | $30.00M | $30.11M | $29.52M | $27.79M | $25.66M | $25.41M | $20.94M |
| Total Operating Expenses | $39.63M | $39.74M | $39.72M | $38.48M | $36.74M | $34.49M | $35.13M | $30.67M |
| **Operating Income** | -$8.42M | -$11.40M | -$18.46M | -$5.59M | -$9.19M | -$10.62M | -$14.97M | $2.99M |
| **EBITDA** | -$6.31M | -$9.39M | -$16.60M | -$3.70M | -$7.27M | -$8.73M | -$13.10M | $4.84M |
| Interest Income | $1.02M | $819K | $787K | $580K | $573K | $555K | $508K | $913K |
| Interest Expense | $260K | $281K | $262K | -$725K | $494K | $414K | $291K | -$5.93M |
| Income Before Tax | -- | -- | -- | -$4.03M | -$7.77M | -$6.78M | -$11.27M | $10.32M |
| Income Tax Expense | -$811K | $515K | $1.49M | $40.05M | -$2.29M | -$1.19M | $136K | $680K |
| **Net Income** | -$6.10M | -$12.16M | -$18.87M | -$44.08M | -$5.48M | -$5.58M | -$11.40M | $9.64M |
| Basic Shares Outstanding | 130.4M | 129.5M | 128.7M | -- | 127.5M | 126.9M | 128.3M | -- |
| Diluted Shares Outstanding | 130.4M | 129.5M | 128.7M | -- | 127.5M | 126.9M | 128.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $90.85M | $98.72M | $167.3M | $296.6M | $364.6M | $165.2M |
| **Cash & Short-Term Investments** | $90.85M | $98.72M | $167.3M | $296.6M | $364.6M | $165.2M |
| Accounts Receivable, Net | $62.51M | $60.59M | $55.93M | $48.86M | $29.76M | $16.99M |
| Inventory | $48.43M | $43.89M | $60.88M | $48.15M | $32.17M | $23.02M |
| Other Current Assets | $2.98M | $1.94M | $2.23M | $3.80M | $708K | $445K |
| **Total Current Assets** | $392.0M | $396.4M | $392.1M | $454.0M | $431.7M | $208.6M |
| Property, Plant & Equipment, Net | $18.01M | $17.96M | $18.41M | $13.68M | $5.85M | $2.14M |
| Goodwill | $16.70M | $16.66M | $16.18M | $10.14M | $10.14M | $476K |
| Intangible Assets | $16.82M | $20.13M | $23.08M | $4.33M | $4.74M | $274K |
| Other Non-Current Assets | $6.70M | $4.76M | $3.38M | $2.96M | $1.67M | $1.09M |
| **Total Non-Current Assets** | $69.55M | $103.1M | $102.4M | $65.46M | $31.57M | $11.36M |
| **Total Assets** | $461.5M | $499.5M | $494.5M | $519.5M | $463.3M | $220.0M |
| Accounts Payable | $6.41M | $5.53M | $3.03M | $4.80M | $3.03M | $2.94M |
| Deferred Revenue (Current) | $28.50M | $25.49M | $22.70M | $26.11M | $16.87M | $7.12M |
| Other Current Liabilities | $16.98M | $13.49M | $7.90M | $7.96M | $6.35M | $4.63M |
| **Total Current Liabilities** | $77.80M | $67.66M | $56.23M | $49.04M | $33.18M | $26.54M |
| Deferred Revenue (Non-Current) | $18.34M | $16.10M | $15.13M | $13.12M | $9.79M | $3.46M |
| Other Non-Current Liabilities | $2.31M | $2.36M | $2.43M | $1.59M | $1.20M | $737K |
| **Total Non-Current Liabilities** | $42.00M | $36.10M | $45.17M | $44.89M | $24.74M | $15.15M |
| **Total Liabilities** | $119.8M | $103.8M | $101.4M | $93.93M | $57.92M | $41.69M |
| **Total Debt (incl. Leases)** | $16.92M | $11.31M | $11.92M | $15.24M | -- | -- |
| Common Stock | $129K | $129K | $131K | $135K | $126K | $23K |
| Retained Earnings | -$101.7M | -$35.20M | -$29.18M | -$17.03M | -$19.61M | -$22.61M |
| Accumulated Other Comp. Income | $2.24M | $16K | -$1.27M | -$697K | $897K | $65K |
| **Total Stockholders' Equity** | $341.7M | $395.7M | $393.1M | $425.5M | $405.4M | -$16.03M |
| Total Equity | $341.7M | $395.7M | $393.1M | $425.5M | $405.4M | -$16.03M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $66.81M | $73.85M | $65.67M | $90.85M | $93.28M | $75.47M | $95.30M | $98.72M |
| **Cash & Short-Term Investments** | $66.81M | $73.85M | $65.67M | $90.85M | $93.28M | $75.47M | $95.30M | $98.72M |
| Accounts Receivable, Net | $59.19M | $49.70M | $51.90M | $62.51M | $56.63M | $56.23M | $55.03M | $60.59M |
| Inventory | $52.37M | $52.25M | $49.79M | $48.43M | $51.65M | $49.49M | $45.35M | $43.89M |
| Other Current Assets | $2.69M | $5.48M | $3.60M | $2.98M | $2.92M | $2.76M | $2.29M | $1.94M |
| **Total Current Assets** | $378.9M | $377.9M | $379.3M | $392.0M | $388.5M | $382.8M | $380.5M | $396.4M |
| Property, Plant & Equipment, Net | $20.61M | $20.80M | $20.47M | $18.01M | $18.05M | $18.35M | $17.83M | $17.96M |
| Goodwill | $16.69M | $16.69M | $16.69M | $16.70M | $16.70M | $16.71M | $16.68M | $16.66M |
| Intangible Assets | $14.03M | $14.87M | $15.70M | $16.82M | $17.68M | $18.60M | $19.43M | $20.13M |
| Other Non-Current Assets | $5.55M | $5.68M | $6.31M | $6.70M | $4.46M | $4.68M | $4.57M | $4.76M |
| **Total Non-Current Assets** | $67.21M | $69.00M | $69.81M | $69.55M | $106.4M | $110.5M | $102.1M | $103.1M |
| **Total Assets** | $446.1M | $446.9M | $449.1M | $461.5M | $494.9M | $493.3M | $482.6M | $499.5M |
| Accounts Payable | $4.89M | $8.41M | $6.74M | $6.41M | $7.63M | $6.85M | $6.25M | $5.53M |
| Deferred Revenue (Current) | $30.28M | $29.21M | $30.03M | $28.50M | $28.74M | $28.13M | $27.71M | $25.49M |
| Other Current Liabilities | $20.21M | $20.51M | $22.17M | $16.98M | $16.43M | $14.72M | $12.84M | $13.49M |
| **Total Current Liabilities** | $84.95M | $84.33M | $80.94M | $77.80M | $75.21M | $73.27M | $67.69M | $67.66M |
| Deferred Revenue (Non-Current) | $18.74M | $18.06M | $17.67M | $18.34M | $16.32M | $16.62M | $15.72M | $16.10M |
| Other Non-Current Liabilities | $2.33M | $2.46M | $2.40M | $2.31M | $2.52M | $2.48M | $2.38M | $2.36M |
| **Total Non-Current Liabilities** | $39.84M | $40.65M | $40.53M | $42.00M | $41.14M | $42.49M | $35.28M | $36.10M |
| **Total Liabilities** | $124.8M | $125.0M | $121.5M | $119.8M | $116.3M | $115.8M | $103.0M | $103.8M |
| **Total Debt (incl. Leases)** | $16.23M | $16.79M | $16.39M | $16.92M | $16.59M | $17.44M | $10.99M | $11.31M |
| Common Stock | $131K | $130K | $129K | $129K | $128K | $127K | $128K | $129K |
| Retained Earnings | -$138.9M | -$132.8M | -$120.6M | -$101.7M | -$57.66M | -$52.18M | -$46.60M | -$35.20M |
| Accumulated Other Comp. Income | $2.64M | $2.74M | $2.37M | $2.24M | $821K | -$38K | -$609K | $16K |
| **Total Stockholders' Equity** | $321.4M | $322.0M | $327.6M | $341.7M | $378.6M | $377.6M | $379.6M | $395.7M |
| Total Equity | $321.4M | $322.0M | $327.6M | $341.7M | $378.6M | $377.6M | $379.6M | $395.7M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$66.54M | -$6.02M | -$12.15M | $2.48M | $3.03M | $19.41M |
| Depreciation & Amortization | $7.58M | $7.21M | $6.05M | $2.49M | $1.24M | $603K |
| Stock-Based Compensation | $24.59M | $26.85M | $22.05M | $16.59M | $6.59M | $611K |
| Change in Receivables | $368K | -$5.43M | -$7.33M | -$19.74M | -$12.37M | $334K |
| Change in Inventory | -$5.24M | $14.76M | $4.29M | -$17.65M | -$7.07M | -$5.70M |
| Change in Payables | $448K | $2.58M | -$1.78M | $1.86M | -$256K | $55K |
| **Operating Cash Flow** | -$4.69M | $25.38M | $5.28M | -$12.23M | $4.63M | $15.16M |
| Capital Expenditure | -$4.08M | -$3.52M | -$4.65M | -$9.75M | -$4.36M | -$1.55M |
| **Free Cash Flow** | -$8.77M | $21.85M | $633K | -$21.98M | $266K | $13.61M |
| **Investing Cash Flow** | $10.12M | -$82.97M | -$93.89M | -$55.91M | -$20.99M | -$1.55M |
| Share Repurchases | -$15.07M | -$21.61M | -$44.15M | $0 | $0 | -- |
| **Financing Cash Flow** | -$13.43M | -$15.82M | -$41.81M | $5.51M | $213.6M | $122.6M |
| **Net Change in Cash** | -$7.89M | -$68.89M | -$131.9M | -$65.12M | $198.5M | $135.6M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.10M | -$12.16M | -$18.87M | -$44.08M | -$5.48M | -$5.58M | -$11.40M | $9.64M |
| Depreciation & Amortization | $2.11M | $2.01M | $1.86M | $1.90M | $1.92M | $1.89M | $1.88M | $1.85M |
| Stock-Based Compensation | $4.85M | $5.34M | $4.86M | $5.53M | $5.64M | $6.79M | $6.63M | $7.00M |
| Change in Receivables | -$10.08M | $1.97M | $9.64M | -$6.15M | -$587K | $652K | $6.45M | -$9.33M |
| Change in Inventory | -$222K | -$2.86M | -$1.63M | $2.05M | -$2.22M | -$3.57M | -$1.50M | $2.00M |
| Change in Payables | -$3.57M | $1.74M | $390K | -$1.31M | $588K | $759K | $410K | $258K |
| **Operating Cash Flow** | -$4.45M | $1.37M | -$2.74M | -$771K | -$3.90M | $108K | -$125K | $2.00M |
| Capital Expenditure | -$1.51M | -$2.22M | -$2.17M | -$1.00M | -$657K | -$1.58M | -$849K | -$894K |
| **Free Cash Flow** | -$5.96M | -$849K | -$4.90M | -$1.77M | -$4.55M | -$1.47M | -$974K | $1.10M |
| **Investing Cash Flow** | -$1.80M | $7.02M | -$27.08M | -$1.84M | $18.92M | -$16.41M | $9.45M | -$63.43M |
| Share Repurchases | $0 | $0 | $0 | $34K | $29K | -$4.51M | -$10.63M | -$7.00M |
| **Financing Cash Flow** | -$561K | -$814K | $3.98M | -$1.23M | $1.94M | -$2.60M | -$11.54M | -$3.64M |
| **Net Change in Cash** | -$6.66M | $8.18M | -$25.19M | -$2.43M | $17.81M | -$19.83M | -$3.45M | -$63.56M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 51.8% | 55.4% | 56.7% | 3407.8% | 3628.8% | 7283.1% |
| **Operating Margin** | -20.0% | -10.2% | -14.4% | -60.9% | 419.9% | 1923.8% |
| **Net Profit Margin** | -33.0% | -3.0% | -6.3% | 83.8% | 138.8% | 2733.9% |
| Return on Equity (ROE) | -19.5% | -1.5% | -3.1% | 0.6% | 0.7% | -- |
| Return on Assets (ROA) | -14.4% | -1.2% | -2.5% | 0.5% | 0.7% | 8.8% |
| Current Ratio | 5.04x | 5.86x | 6.97x | 9.26x | 13.01x | 7.86x |
| Quick Ratio | 4.42x | 5.21x | 5.89x | 8.28x | 12.04x | 6.99x |
| Debt to Equity | 0.05x | 0.03x | 0.03x | 0.04x | -- | -- |
| **Revenue Growth (YoY)** | +0.5% | +3.9% | +6414.2% | +35.9% | +207.2% | -- |
| Gross Profit Growth (YoY) | -6.0% | +1.5% | +8.4% | +27.6% | +53.1% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -119.7% | -33.0% | -- |
| **Net Income Growth (YoY)** | -- | -- | -589.0% | -17.9% | -84.4% | -- |
| EPS Growth (YoY) | -- | -- | -550.0% | -- | -100.0% | -- |
| Operating Cash Flow Growth (YoY) | -118.5% | +380.6% | -- | -364.2% | -69.5% | -- |
| Free Cash Flow Growth (YoY) | -140.1% | +3352.4% | -- | -8362.8% | -98.0% | -- |
| 5Y Revenue / Share Growth | +8527.3% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -204.2% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 54.7% | 53.2% | 51.7% | 51.8% | 53.5% | 54.4% | 54.9% | 55.4% |
| **Operating Margin** | -21.1% | -21.6% | -21.5% | -20.0% | -16.2% | -13.7% | -12.6% | -10.2% |
| **Net Profit Margin** | -39.1% | -39.0% | -36.2% | -33.0% | -6.5% | -3.3% | -5.7% | -3.0% |
| Return on Equity (ROE) | -25.3% | -25.0% | -22.6% | -19.5% | -3.4% | -1.7% | -3.0% | -1.5% |
| Return on Assets (ROA) | -18.2% | -18.0% | -16.5% | -14.4% | -2.6% | -1.3% | -2.3% | -1.2% |
| Current Ratio | 4.46x | 4.48x | 4.69x | 5.04x | 5.17x | 5.22x | 5.62x | 5.86x |
| Quick Ratio | 3.84x | 3.86x | 4.07x | 4.42x | 4.48x | 4.55x | 4.95x | 5.21x |
| Debt to Equity | 0.05x | 0.05x | 0.05x | 0.05x | 0.04x | 0.05x | 0.03x | 0.03x |
| **Revenue Growth (YoY)** | +1.8% | +5.6% | +6.5% | +8.1% | +1.5% | -2.2% | -7.6% | -1.3% |
| Gross Profit Growth (YoY) | +13.3% | +18.7% | +5.4% | -2.3% | -5.0% | -6.2% | -12.4% | +1.8% |
| Operating Income Growth (YoY) | -- | -- | -- | -287.3% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -557.1% | -682.1% | -- | -- | +75.2% |
| Operating Cash Flow Growth (YoY) | -- | +1165.7% | -- | -138.6% | -129.5% | -98.3% | -103.2% | -79.0% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -260.7% | -137.3% | -128.5% | -128.7% | -86.2% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
